RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Applying CIRS-BRAT framework in a regulatory setting
Updated benefit risk assessment for fibrinogen concentrate in the setting of complex cardiac surgery
Gilsenan, A. W., Brainsky, A., & Colilla, S. (2019). Applying CIRS-BRAT framework in a regulatory setting: Updated benefit risk assessment for fibrinogen concentrate in the setting of complex cardiac surgery. Pharmacoepidemiology and Drug Safety, 28(Suppl 2), 964. https://doi.org/10.1002/pds.4864